These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Penicillin gets some help against resistant pathogens. Henehan J JAMA; 1982 Nov; 248(19):2427. PubMed ID: 6922944 [No Abstract] [Full Text] [Related]
29. [Experimental and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the field of pediatrics]. Minamitani M; Hachimori K; Kaneda K Jpn J Antibiot; 1985 Feb; 38(2):415-22. PubMed ID: 4009950 [TBL] [Abstract][Full Text] [Related]
30. Amoxycillin/clavulanate in acute purulent exacerbations of chronic bronchitis. Maesen FP; Davies BI; Baur C J Antimicrob Chemother; 1987 Mar; 19(3):373-83. PubMed ID: 3494724 [TBL] [Abstract][Full Text] [Related]
31. In-vitro activity of augmentin against clinically important gram-positive and gram-negative bacteria in comparison with other antibiotics. Focht J; Klietmann W; Heilmann HD Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Apr; 256(4):523-30. PubMed ID: 6564828 [TBL] [Abstract][Full Text] [Related]
32. [In vitro susceptibilities of causative organisms isolated from patients with primary respiratory tract infections to BRL 25000 (clavulanic acid/amoxicillin)]. Deguchi K; Fukayama S; Nishimura Y; Yokota N; Tanaka S; Oda S; Matsumoto Y; Ikegami R; Sato K; Fukumoto T Jpn J Antibiot; 1985 Oct; 38(10):2797-808. PubMed ID: 3878415 [TBL] [Abstract][Full Text] [Related]
33. [Clinical study of amoxicillin used in the otorhinolaryngological field (author's transl)]. Okamoto K; Yoshida A; Kona A; Ikeda M; Muraoka J Jpn J Antibiot; 1976 Jan; 29(1):22-6. PubMed ID: 1263338 [TBL] [Abstract][Full Text] [Related]
34. Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients. Schaad UB; Casey PA; Cooper DL Antimicrob Agents Chemother; 1983 Feb; 23(2):252-5. PubMed ID: 6838187 [TBL] [Abstract][Full Text] [Related]
35. Augmentin (Amoxycillin and clavulanic acid) in the treatment of urinary tract infections and skin and soft tissue infections. Tan TH; Tay L; Yeo M; Feng PH Singapore Med J; 1983 Oct; 24(5):299-302. PubMed ID: 6669995 [No Abstract] [Full Text] [Related]
36. [Preliminary evaluation of the sensitivity of selected bacteria to amoxicillin and augmentin in comparison with other antibiotics used to date]. Ruczkowska J; Dolna I Przegl Lek; 1984; 41(4):321-4. PubMed ID: 6565294 [No Abstract] [Full Text] [Related]
38. The efficacy of augmentin as a beta-lactam antibiotic in surgical and medical practice. Kirei BR; Mhalu FS; Pallangyo PK; Seif SA East Afr Med J; 1987 Jul; 64(7):499-503. PubMed ID: 3691365 [No Abstract] [Full Text] [Related]
39. Beta-lactamase inhibitors: another approach to overcoming antimicrobial resistance. Parker RH; Eggleston M Infect Control; 1987 Jan; 8(1):36-40. PubMed ID: 3028975 [TBL] [Abstract][Full Text] [Related]
40. Comparative activity of BRL 25.000 with amoxycillin against resistant clinical isolates. Van Landuyt HW; Pyckavet M; Lambert AM J Antimicrob Chemother; 1981 Jan; 7(1):65-70. PubMed ID: 6907270 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]